CDNA

CareDx, Inc.

14.16 USD
-0.03 (-0.21%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

CareDx, Inc. stock is down -8.65% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 70% of the previous 9 June’s closed higher than May. 0% of analysts rate it a buy.

About CareDx, Inc.

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients. AlloSeq Tx, a high-resolution HLA typing solution, is used to type human leukocyte antigen (HLA) alleles.